Kroeger Financial Partners’s Edwards Lifesciences EW Stock Holding History

Kroeger Financial Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.1K	Buy	+720	New	+$60.3K	0.06%	77

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Kroeger Financial Partners's EW Position: Q2 2026 in Review

Kroeger Financial Partners opened a new position in Edwards Lifesciences (EW) in Q2 2026: 720 shares worth $65.1K. The stake represents 0.06% of the portfolio and ranks #77 among its holdings.

467 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Kroeger Financial Partners held 720 shares of Edwards Lifesciences worth $65.1K as of Q2 2026.
Edwards Lifesciences was a new Kroeger Financial Partners position in Q2 2026.
Edwards Lifesciences made up 0.06% of Kroeger Financial Partners's portfolio in Q2 2026, its #77 holding.
467 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kroeger Financial Partners's 13F filing for Q2 2026, filed 27 Jul 2026.